OZONEHOSPITAL.COM
Dear People of the World:
We would like to introduce ourselves as the largest
Medical Ozone centers in Malaysia, First to Provide Ground - Breaking Therapy in
Treatment and Prevention of Coronary Artery Disease. We would like therefore
make excellence the only acceptable standard of your care.
Alif-1 EBOO SAFE - has set a benchmark, by its
self-recognition in playing the key role in the treatment and Prevention of
Coronary Artery Disease. No Cardiologist, Medical Professional, or Coronary
Heart Disease Patient can afford to ignore this vital role Alif-1
EBOO SAFE.
As a leader in the discovery, development,
manufacture, training, certification and marketing of Alif 1 EBOO SAFE
we are committed to improving health and well-being through innovative
treatment, products and services. We share the medical world's goal of bringing
safer and more effective products to the market as promptly as possible.
Before we introduce our treatment, products and
services, allow us to give a brief about ozone therapy which began in 1870 in
Germany and now approved in more than 25 countries all around the world
including Germany, Italy, Japan, Austria, Switzerland, Cuba and some states in
the US plus many more. There are 2,000 ozone clinics in Europe alone.
The therapeutic use of ozone has an excellent safety
record and no toxic effects have been observed from clinical use. The use of
ozone as a healing adjunct is well established and is being vigorously pursued
by many scientists and clinicians. The benefits are predictable and without side
effects. As technology advances, undoubtedly new techniques will enlarge the
scope of the effective use of this versatile modality.
Now let us introduce our main topic- Alif 1
EBOO SAFE, the therapeutic ozoniser, an equipment that produces automatically
different ozone concentrations in continuous and reproducible ways in all of
ozone's therapeutic range.
It can be used in all ozone medical applications known
at present, for example, optic neuropathy, chronic glaucoma, cochleovestibular
syndrome, retinitis pigmentosa, senile dementia, sickle cell anemia, sepsis
prevention, arthorosis, obliterant arteriopathy, ulcers of the limb, diabetic
foot, radiological contrast in diaphragmatic angiography. In general, in the
specialties of ophthalmology, geriatrics, orthopedics, angiology and internal
medicine.
Alif 1 EBOO SAFE are the names of the ozone
generators. As the function implies, Alif 1 EBOO SAFE generates ozone upon
introduction of medical oxygen into the unit. Our procedure, known as EBOO (Extracorporeal Blood Oxygenation and
Ozonation) is similar to haemodylisis. In this case, Alif 1 EBOO is born
as remedy to many cardiological problems, without undergoing the threatening
high risk, painful, expensive and complicated procedures of surgery.
Specialized ozone therapy centers, on administrating
the non- invasive therapy Alif 1 EBOO SAFE to severe coronary artery
disease patients, have found amazing results.
Through years of extensive research, we have developed
an apparatus called Alif 1 EBOO SAFE that facilitates to treat 3 to 4
liters of blood with medical ozone in extracorporeal circulation for a period 60
to 90 minutes of patients with coronary heart disease. Alif 1 EBOO SAFE
has proven to be second to none in delivering its role in the procedural assay
of safe straight to the heart.
To achieve satisfactory result, one has to undergo 15
to 35 hours therapy depending on the state of the disease.
Alif 1 EBOO SAFE is performed by withdrawing
venous blood and the same blood is infused into an oxygen-ozone gas exchange
filter in and upward direction, using a specialized guideline with a
computerized peristaltic pump controlling the rate of withdrawal. Medical ozone
from the unit is introduced into this hydrophobic and ozone resistant gas
exchange filter in the opposite direction from top going downwards and ozonation
of blood begins. To avoid coagulation during the process of Alif 1 EBOO
SAFE treatment, heparinazation of the blood is done but not absolutely necessary
as there are other means, just before the blood is infused into the filter.
After passing through the oxygen-ozone gas exchange filter, treated blood is
re-infused in to the patient. Upon establishment of extracorporeal circuit, the
withdrawal rate will be increased to a range of 60-80 ml per minute, depending
on the condition of the patient.
RESULTS
It has been established by various scientific
researchers that reinfusion oxygenated and ozonated blood enhances the release
of nitric oxide and interleukin-8 in the human endothelial cells (the layer of
cells lining on the artery wall).
Achieved results of the therapy in general from
various conditions of patients shows:
1. Improved Vasodilatation
(stretching of a vessel/arteriole beyond its normal dimension leading to
increased blood flow) in ischemic areas.
2. Reduced hypoxia (reduction of oxygen carrying
capacity of blood)
3. Induced Neoangiogenesis (formation of new blood
vessels) due to enhanced release of nitric oxide.
That completes the explanation on Alif 1 EBOO
and now let us introduce SAFE.
SAFE is a device-based therapy intended to remove
extra fluid from blood and body ; Simple Access Fluid Extraction (SAFE) as the
name implies. Patients with heart failure typically are treated with various
medications, including angiotensin-converting enzyme inhibitors, beta-blockers,
diuretics, and inotropic drugs. Although these drugs don't stop disease
progression, they may reduce symptoms and improve functional capacity. Over
time, however, some patients stop responding to these therapies.
SAFE , a process that removes fluid from the
intravascular compartment, can help ease symptoms for these patients. It may
even help patients respond again to conventional drug therapy.
During SAFE, the patient intravascular fluid remains
stable, as fluid shifts from extravascular space that lost from the vessels.
This reduces edema and third spacing. But because fluid is not removed from the
vascular compartment any faster than it can be recruited from the peripheral
tissues, patients do not become hypotensive- the plasma refilling rate is
adequate to prevent hypovolemia. The patient's heart rate, blood pressure and
serum electrolytes also remain largely unchanged.
In general, SAFE improves the quality of life with the
ceasing of anginal pain and increase of functional abilities. We are proud to
say that SAFE is a truly high quality Malaysian invention by a team of medical
experts and engineers.
We would also like to dedicate our sincere
appreciation to the 1998 Nobel Prize Winners in Physiology or Medicine for their
discoveries concerning nitric oxide as a signaling molecules in the
cardiovascular system- Robert F. Furchgott (SUNY Health Science Center Brooklyn,
New York, USA), Louis J. Ignarro (University of California School of Medicine)
and Ferid Murad (University of Texas) for their discoveries concerning the role
of nitric oxide as a signaling molecule in the cardiovascular system. These
medical experts have given us the inspiration and encouragement to come up with
our invention SAFE.
May God Bless You And Keep You Well
Peter (Professor Ozone) Jovanovic
